Companies › ATNM

ACTINIUM PHARMACEUTICALS INC (ATNM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001388320 · EDGAR filings · Updated 2026-06-18

ACTINIUM PHARMACEUTICALS INC (ATNM) has reported institutional ownership of 16.9%, with 54 institutional managers holding positions valued at $5.27M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Latest updates

• 2026-06-18 — Current report (8-K) filed
• 2026-05-29 — Current report (8-K) filed
• 2026-05-08 — Quarterly report (10-Q) filed
• 2026-03-30 — Annual report (10-K) filed
• 2026-03-26 — Amended current report (8-K/A) filed
• 2026-02-13 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ACTINIUM PHARMACEUTICALS INC has 54 institutional holders and institutional ownership of 16.9%.

Insider activity

Insiders reported 1 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Vivani Medical Inc (VANI) · IN8BIO INC (INAB) · ESTRELLA IMMUNOPHARMA INC (ESLA) · Lisata Therapeutics Inc (LSTA) · PAVmed Inc (PAVM) · MINDWALK HOLDINGS CORP COM (HYFT)